Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinomaDhruva Biswas, Carlos Martínez‐Ruiz, Yun-Hsin Liu et al.|Nature Cancer|2025Cited by 15
The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differScott Greenfeder, John C. Anthes, Elizabeth Keene et al.|Bioorganic & Medicinal Chemistry|1999Cited by 14